Default company panoramic image
752e438e e7db 4074 afd2 959c86420807


Uriprene is launching a degradable urinary tract stent which will eliminate the need for painful and costly stent removals.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Charlotte, NC, USA
  • Currency USD
  • Founded February 2012
  • Employees 1

Company Summary

Uriprene, Inc. is actively engaged in the commercialization of non-vascular stents. Development of the Company’s lead product, a degradable ureteral stent, was initiated in 2006 by Poly-Med, Inc. Uriprene was spun out after all preclinical developments and testing were successfully completed in January 2012.


  • Default avatar
    Tanner Hargens
    President and CEO

    I am an engineer and entrepreneur, taking novel medical devices from concept to market. I received my BS in Biomedical Engineering and MS in Biomaterials. Extending beyond my engineering background, I manage startups and am cross-functionally involved with product development, patent protection, preclinical testing, clinical trials, the regulatory approval process, and early sales.

Previous Investors

  • Default avatar
    Poly-Med, Inc.